Different steps of the fabrication process. by Md. Abu Daud (21485629)

Subjects:

Schematic representation of the main steps from gray images to the corresponding graph of the segmented regions. by Zakaria Belghali (22581967)

Subjects:

Trends of incident opioid users, L-TOT users, and L-TOT discontinuers between 2009 and 2013. by Qian Cai (112039)

Subjects:

The yearly numerator, denominator and rate of incident opioid users, L-TOT users and L-TOT discontinuers from 2009 to 2019. by Qian Cai (112039)

Subjects:

Incidence rate ratios of negative binominal regression models for yearly rates of incident opioid users, L-TOT users and L-TOT discontinuers during 2009–2013 and 2015–2019. by Qian Cai (112039)

Subjects:

Demographic, comorbidity, concurrent drug, and opioid characteristics, among L-TOT users and L-TOT discontinuers between 2009–2019. by Qian Cai (112039)

Subjects:

Tissue, days post-infection (dpi) and the top 10 most significant genes with increased and decreased expression with valid gene symbols for the response contrasts. by Gillian P. McHugo (8965919)

RTL8 incorporates into PEG10 VLPs and decreases the efficiency of release. by Will Campodonico (20485651)

Subjects:

CS rates increased with protraction and decreased with retraction. by Paul Hage (21071783)

In vivo combination activity of AMG 510 and pemigatinib in epithelial-like or mesenchymal-like phenotype lung cancer PDX models. by Angela Abdollahi (15166230)

Subjects:

MigC interacts with and decreases the activity of MurD. by Jeanette M. Critchlow (21553796)

Maximum IFN concentrations are decreased in severe patients. by Sonia T. Gazeau (21512764)

List of eigenvalues, percentages of variance, and factor loadings for the first two principal components of the PCA. by Brienna Eteson (21416834)

Subjects:

Dominant hand %MVC sEMG PCA plot (PC 1 = 70.27% of variance; and PC 2 = 11.59% of variance) PCA plot summarizing overall dominant hand muscular recruitment during all three phases... by Brienna Eteson (21416834)

Subjects:

Stem plot of PC 1 scores (vertical axis), representing all three phases within participants Hold (red); Aim (yellow); Execute (green). by Brienna Eteson (21416834)

Subjects:

%MVC sEMG PCA plot (PC 1  by Brienna Eteson (21416834)

Subjects:

Descriptive statistics of the mean %MVC values for each stage. by Brienna Eteson (21416834)

Subjects:

Beta frequency band maps of all three phases within the Oldowan flake-cutting task and the control task Maps are configured at 0.1–0.6 by Brienna Eteson (21416834)

Subjects:

Table_3_Loss of CDYL Results in Suppression of CTNNB1 and Decreased Endometrial Receptivity.docx by Xiaowei Zhou (1332225)

“…In the present study, we demonstrated that chromodomain Y like (CDYL) was highly expressed in the endometrium at mid-secretory phase during the normal menstrual cycles. …”

Image_4_Loss of CDYL Results in Suppression of CTNNB1 and Decreased Endometrial Receptivity.TIF by Xiaowei Zhou (1332225)

“…In the present study, we demonstrated that chromodomain Y like (CDYL) was highly expressed in the endometrium at mid-secretory phase during the normal menstrual cycles. …”